By hgreaney@athen…, 17 September, 2021 Consider FMT IBD pts4 those who recur w in 8wk of previous FMT2
By hgreaney@athen…, 17 September, 2021 Individualize decision to withhold continue increase immunosuppression in IBD pts per AGA 4 though ACG recommends against holding immunosuppressants 2 may be reasonable to start steroids or uarr immunosuppression after a few days of abx if no improvement2
By hgreaney@athen…, 17 September, 2021 Avoid antimotility agents in untreated CDI but they can be used safely on an as needed basis after anti CDI tx initiated2
By hgreaney@athen…, 17 September, 2021 Consider adding bezlotoxumab to SOC abx in adults if recurrence w in 6mo or if 65 yo or immunocompromised 6 per ACG reserve for pts who recurred w in 6mo but also for those both age 65 yo immunocompromised7
By hgreaney@athen…, 17 September, 2021 In children metronidazole recommended as initial agent by AAP 3 but vancomycin also 1st line per IDSA5
By hgreaney@athen…, 17 September, 2021 In IBD vancomycin preferred per ACG 2 though AGA suggests fidaxomicin as option4
By hgreaney@athen…, 17 September, 2021 Use fidaxomicin over vancomycin in adults per IDSA 1 both are options per ACG but not in pregnancy breastfeeding 2 or children3
By hgreaney@athen…, 17 September, 2021 D c precipitating antibiotic fidaxomicin now preferred in adults by IDSA but vancomycin remains an option consider bezlotoxumab if CDI recurred w in 6mo of last episode in certain other pts consider FMT in IBD pts
